Clinical trial
CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)
NCT00211939 is registered in ClinicalTrials.gov with Nabi Biopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)
- Lead sponsor
- Nabi Biopharmaceuticals
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- March 31, 2007
- Enrollment
- 203 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.